What's The BUZZ?

Market News, Products, Services, and Trends

DDWatch February 2023: Missing Opioids, Patient Harm and Hospital Standards

ddwatch.JPG


ST. LOUIS (February 17, 2023) – The newest issue of Drug Diversion Watch (DDWatch) was released this week, featuring the latest information about drug diversion across the U.S. in one location. 

Initially established by ANiGENT as a watchdog tool, the free newsletter has since become one of the fastest-growing news sources shared in the industry. The newsletter is now requested by hospital administrators, pharmacy directors, and other healthcare workers involved in drug diversion prevention.

Here are some of the headlines reported on the latest issue of DDWatch:

     – Thousands of fentanyl doses reported missing in a Missouri hospital

     – Drug diversion arrests increased by 40% in Pennsylvania

     – The slow process of drug diversion investigations can delay suspension and contribute to potential harm

     – The Joint Commission standards on medication management

To read the rest of this month’s DDWatch, click here. To subscribe and receive the newsletter in your inbox every month, click here.


ANiGENT

ANiGENT News & Announcements

ANiGENT was established in 2019 to deliver a comprehensive, patent-pending drug diversion detection platform: Medication Administration & Analysis Program (MAAP Analytics®). Built by clinicians for clinicians and backed by over 10 years of refinements in a clinical setting, MAAP Analytics uses machine learning to track all users, all medications, in all locations and identify the root cause of discrepancies in minutes. Purpose-built and proven to produce actionable intelligence, MAAP Analytics is operationally efficient and configurable to any facility’s requirements. To learn more about ANiGENT and MAAP Analytics, visit ANiGENT.com.

10-rxinsider-staff

Posted by: RXinsider Staff

RXinsider is a multimedia publishing and technology company offering print publications, digital platforms, events, and content creation services to the B2B pharmacy market.

This post is related to:

SUBSCRIBE

Please enable JavaScript in your browser to complete this form.
Name
Subscription Choices
Checkboxes

Request information from DDWatch February 2023: Missing Opioids, Patient Harm and Hospital Standards

Please enable JavaScript in your browser to complete this form.
Name
Address
Subscribe